| Dr Clifford J Fields, DO | |
|
725 Reservoir Ave Ste 103, Cranston, RI 02910-4451 | |
| (401) 829-4446 | |
| (401) 829-4434 |
| Full Name | Dr Clifford J Fields |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 39 Years |
| Location | 725 Reservoir Ave Ste 103, Cranston, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619901147 | NPI | - | NPPES |
| DO00356 | Other | RI | OSTEOPATHIC PHYSICIAN |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Angell Street Psychiatry Ltd | 5496656977 | 8 |
News Archive
ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.
The Massage Therapy Foundation has awarded $210,000 for a research grant to the Defense and Veterans Center for Integrative Pain Management, Rockville, Md. Dr. Krista Highland, Deputy Director of Science, DVCIPM, is the Primary Investigator of the two-year study, "Massage Service Integration in a Military Primary Care Clinic: Implementation and Impact Study."
A novel, free, public online database opening this week should greatly speed efforts to find genes linked to increase risk of bipolar disorder.
Black men are three times more likely to develop prostate cancer than other demographics, yet black men are consistently underrepresented in research studies, say researchers from King's College London in a new paper published in ecancermedicalscience.
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
› Verified 4 days ago
| Entity Name | Angell Street Psychiatry Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114011756 PECOS PAC ID: 5496656977 Enrollment ID: O20040116001007 |
News Archive
ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.
The Massage Therapy Foundation has awarded $210,000 for a research grant to the Defense and Veterans Center for Integrative Pain Management, Rockville, Md. Dr. Krista Highland, Deputy Director of Science, DVCIPM, is the Primary Investigator of the two-year study, "Massage Service Integration in a Military Primary Care Clinic: Implementation and Impact Study."
A novel, free, public online database opening this week should greatly speed efforts to find genes linked to increase risk of bipolar disorder.
Black men are three times more likely to develop prostate cancer than other demographics, yet black men are consistently underrepresented in research studies, say researchers from King's College London in a new paper published in ecancermedicalscience.
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
› Verified 4 days ago
| Entity Name | Emergency Associates Of Woonsocket Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912342528 PECOS PAC ID: 6002050648 Enrollment ID: O20130920000246 |
News Archive
ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.
The Massage Therapy Foundation has awarded $210,000 for a research grant to the Defense and Veterans Center for Integrative Pain Management, Rockville, Md. Dr. Krista Highland, Deputy Director of Science, DVCIPM, is the Primary Investigator of the two-year study, "Massage Service Integration in a Military Primary Care Clinic: Implementation and Impact Study."
A novel, free, public online database opening this week should greatly speed efforts to find genes linked to increase risk of bipolar disorder.
Black men are three times more likely to develop prostate cancer than other demographics, yet black men are consistently underrepresented in research studies, say researchers from King's College London in a new paper published in ecancermedicalscience.
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
› Verified 4 days ago
| Entity Name | Emergency Care Services Of New England Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639537335 PECOS PAC ID: 9739487562 Enrollment ID: O20160412001747 |
News Archive
ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.
The Massage Therapy Foundation has awarded $210,000 for a research grant to the Defense and Veterans Center for Integrative Pain Management, Rockville, Md. Dr. Krista Highland, Deputy Director of Science, DVCIPM, is the Primary Investigator of the two-year study, "Massage Service Integration in a Military Primary Care Clinic: Implementation and Impact Study."
A novel, free, public online database opening this week should greatly speed efforts to find genes linked to increase risk of bipolar disorder.
Black men are three times more likely to develop prostate cancer than other demographics, yet black men are consistently underrepresented in research studies, say researchers from King's College London in a new paper published in ecancermedicalscience.
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
› Verified 4 days ago
| Entity Name | Trucare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538659081 PECOS PAC ID: 1850646811 Enrollment ID: O20180614001472 |
News Archive
ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.
The Massage Therapy Foundation has awarded $210,000 for a research grant to the Defense and Veterans Center for Integrative Pain Management, Rockville, Md. Dr. Krista Highland, Deputy Director of Science, DVCIPM, is the Primary Investigator of the two-year study, "Massage Service Integration in a Military Primary Care Clinic: Implementation and Impact Study."
A novel, free, public online database opening this week should greatly speed efforts to find genes linked to increase risk of bipolar disorder.
Black men are three times more likely to develop prostate cancer than other demographics, yet black men are consistently underrepresented in research studies, say researchers from King's College London in a new paper published in ecancermedicalscience.
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
› Verified 4 days ago
| Entity Name | Lmw Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447595368 PECOS PAC ID: 7012155112 Enrollment ID: O20190520001320 |
News Archive
ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.
The Massage Therapy Foundation has awarded $210,000 for a research grant to the Defense and Veterans Center for Integrative Pain Management, Rockville, Md. Dr. Krista Highland, Deputy Director of Science, DVCIPM, is the Primary Investigator of the two-year study, "Massage Service Integration in a Military Primary Care Clinic: Implementation and Impact Study."
A novel, free, public online database opening this week should greatly speed efforts to find genes linked to increase risk of bipolar disorder.
Black men are three times more likely to develop prostate cancer than other demographics, yet black men are consistently underrepresented in research studies, say researchers from King's College London in a new paper published in ecancermedicalscience.
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
› Verified 4 days ago
| Entity Name | Blueprint Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467927483 PECOS PAC ID: 1153665062 Enrollment ID: O20200626000337 |
News Archive
ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.
The Massage Therapy Foundation has awarded $210,000 for a research grant to the Defense and Veterans Center for Integrative Pain Management, Rockville, Md. Dr. Krista Highland, Deputy Director of Science, DVCIPM, is the Primary Investigator of the two-year study, "Massage Service Integration in a Military Primary Care Clinic: Implementation and Impact Study."
A novel, free, public online database opening this week should greatly speed efforts to find genes linked to increase risk of bipolar disorder.
Black men are three times more likely to develop prostate cancer than other demographics, yet black men are consistently underrepresented in research studies, say researchers from King's College London in a new paper published in ecancermedicalscience.
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clifford J Fields, DO 725 Reservoir Ave Ste 103, Cranston, RI 02910-4451 Ph: (401) 829-4446 | Dr Clifford J Fields, DO 725 Reservoir Ave Ste 103, Cranston, RI 02910-4451 Ph: (401) 829-4446 |
News Archive
ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.
The Massage Therapy Foundation has awarded $210,000 for a research grant to the Defense and Veterans Center for Integrative Pain Management, Rockville, Md. Dr. Krista Highland, Deputy Director of Science, DVCIPM, is the Primary Investigator of the two-year study, "Massage Service Integration in a Military Primary Care Clinic: Implementation and Impact Study."
A novel, free, public online database opening this week should greatly speed efforts to find genes linked to increase risk of bipolar disorder.
Black men are three times more likely to develop prostate cancer than other demographics, yet black men are consistently underrepresented in research studies, say researchers from King's College London in a new paper published in ecancermedicalscience.
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.
› Verified 4 days ago
Dr. Mark Rosenberg, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 725 Reservoir Ave, Suite 102, Cranston, RI 02910 Phone: 401-943-6910 Fax: 401-946-5130 | |
Jacob Martin Beane, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 712 Oaklawn Ave, Cranston, RI 02920 Phone: 401-944-0044 | |
Dr. Jeanne Wrean Swen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1660 Broad St, Cranston, RI 02905 Phone: 401-784-6963 Fax: 401-784-9087 | |
Jeffrey Wilson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 725 Reservoir Ave, Suite 102, Cranston, RI 02910 Phone: 401-943-6910 Fax: 401-946-5130 | |
Amity Rubeor, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 Sockanosset Cross Rd Ste 301, Cranston, RI 02920 Phone: 401-943-6910 Fax: 401-946-5130 | |
Kathryne Anne Leonard, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 922 Reservoir Ave, Cranston, RI 02910 Phone: 401-946-0884 | |
Sukanya Somasundar, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Pontiac Ave, Cranston, RI 02920 Phone: 401-944-4300 Fax: 401-464-4071 |